Biotech

Category / Pharmaceuticals & Biotech / Biotech

Paladin Labs Reports First Quarter 2013 Results: Achieves Record Revenues

MONTREAL, CANADA: ...

Sernova Provides Corporate Update and Results of 2013 Annual General Meeting

LONDON, ONTARIO: ...

Pacgen Appoints Interim Chief Executive Officer

VANCOUVER, BRITISH COLUMBIA: ...

New England Journal of Medicine Publishes Discovery of Gene Mutation That Causes Sturge-Weber Syndrome and Port-Wine Birthmarks

MT. FREEDOM, NJ: The Sturge-Weber Foundation Applauds Research and Urges Continued Collaboration to Bring New Hope to Families Living With Rare Disorder ...

Jennerex Granted FDA Orphan Drug Designation for Pexa-Vec in Hepatocellular Carcinoma (HCC)

SAN FRANCISCO, CA: Top-Line Data From TRAVERSE, Phase 2b Pexa-Vec Trial in Hepatocellular Carcinoma, Expected at Year End ...

ProMetic Reports Highlights of Its 2012 Annual and Special Meeting of Shareholders and Its First Quarter 2013 Financials Results

LAVAL, QUEBEC: - Revenues of $4.4 million in Q1 2013, an increase of $3.3 million compared to Q1 2012 - Revenues expected to exceed $11.0 million by the end of June 2013, compared to $7.4 million for the first half ...

Portola Announces Its Factor Xa Inhibitor Antidote PRT4445 Produces Rapid, Sustained and Dose-Related Reversal of the Anticoagulant Activity of Eliquis(R) in Phase 2 Study

SOUTH SAN FRANCISCO, CA: Results Are From First in Series of Phase 2 Proof-of-Concept Studies ...

REMINDER: Cornerstone Therapeutics to Host First Quarter 2013 Conference Call

CARY, NC: ...

Russell J. Howard to Join Prima BioMed's Board of Directors

SYDNEY, AUSTRALIA: ...

Insys Announces Closing of Initial Public Offering and Exercise of Underwriters' Over-Allotment Option

PHOENIX, AZ: ...

Sarepta Therapeutics Initiates Dosing in Phase I Multiple Ascending Dose Study of Drug for Treatment of Marburg Virus

CAMBRIDGE, MA: ...

Linkage Biosciences Closes Growth Capital and Inks Distribution Partners

SAN FRANCISCO, CA: ...

LifeSci Advisors Initiates Coverage of Lipocine Inc.

NEW YORK, NY: Potential Best-in-Class Oral Testosterone Replacement Therapy Poised for Phase III Trial; Pipeline Candidates Include Once-Daily Oral TRT and Potential First Oral Drug for the Prevention of Preterm Bi ...

DBV Technologies and Mount Sinai Hospital Enter Into a Research Collaboration Agreement

BAGNEUX, FRANCE: ...

Medivation Announces Participation at Upcoming Investor Conferences

SAN FRANCISCO, CA: ...

Bradmer Announces First Quarter Operational and Financial Results

TORONTO, ONTARIO: ...

Dynavax Reports First Quarter 2013 Financial Results

BERKELEY, CA: ...

Data on Agile Therapeutics' Low-Dose Contraceptive Patch (AG200-15) Presented at American College of Obstetricians and Gynecologists' (ACOG) Annual Clinical Meeting

PRINCETON, NJ: Two Poster Presentations Include Combined Data From Two Phase 3 Studies ...

Artificial Intelligence-Based Technology Yielding Positive Results in Drug Discovery Collaborations

LONDON, ONTARIO: Critical Outcome Technologies provides update on progress to date ...

RepliCel's Chief Scientific Officer Updates World Congress for Hair Research on 12-Month Safety Data from Its Phase I Clinical Trial